Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

APAC deal activity falls 8% YoY in first eight months of 2026 amid M&A slump, reveals GlobalData

Deal activity across the Asia-Pacific (APAC) region declined during January to August 2026 compared to the same period in 2025, in line with the global trend. Subdued deal-making sentiment, ongoing macroeconomic volatility, and selective capital deployment continued to impact deal landscape. The total number of deals (comprising mergers & acquisitions (M&A), private equity and venture […]
Read more

Australia’s accelerated coal phase-out demands swift dispatchable capacity replacement, says GlobalData

Australia operates one of the world’s fastest-decarbonizing power systems, marked by a rapid structural shift away from thermal baseload generation toward solar, wind, and storage. With the retirement of major coal-fired power stations accelerating and the federal 82% renewable electricity target for 2030 approaching, the country is deploying substantial market and policy mechanisms to safeguard […]
Read more

China expands role in manufacturing new FDA-approved drugs, says GlobalData

Biopharma companies are increasingly choosing to manufacture their newer FDA-approved innovator and biosimilar products at facilities in China, signaling growing industry confidence in using the country as one of the bases for its manufacturing, according to GlobalData, a leading intelligence and productivity platform. Katia Djebbar, Pharma Analyst at GlobalData, comments: “The FDA-approved products currently being […]
Read more

Global deal activity falls 4% YoY during January–August 2026, finds GlobalData

Persistent macroeconomic uncertainty, elevated financing costs, and geopolitical headwinds continued to weigh on dealmaking activity, resulting in a 4% year-on-year (YoY) decline in the total number of deals (comprising mergers & acquisitions (M&A), private equity, and venture capital (VC)) announced globally during January–August 2026 compared with the same period in 2025, according to GlobalData, a […]
Read more

South Korea’s dry eye market to see intensified competition with third homegrown drug approval, says GlobalData

South Korea’s Ministry of Food and Drug Safety has approved recoflavone (Latica/Recodu) for moderate to severe dry eye disease. Developed jointly by GL PharmaTech and Aju Pharmaceutical, recoflavone is the first domestically developed dry eye disease treatment approved in South Korea and the third prescription treatment authorized for the indication. The approval is expected to […]
Read more

Porsche’s battery recycling signals next phase of EV supply chain localization in Europe, says GlobalData

Battery-material supply chains are tightening as electric vehicle (EV) volumes rise, critical-mineral prices remain volatile, and regulation pushes manufacturers toward traceability and recycled content. Porsche has now produced battery cells using cathode active material made entirely from recycled lithium, nickel, cobalt, and manganese under a high-voltage battery recycling pilot launched with partners including German recycler […]
Read more

India to emerge as second-largest contributor to global urea capacity additions by 2030, says GlobalData

India is poised to witness significant urea capacity additions by 2030, driven primarily by the need to curb heavy import dependence, achieve self-reliance, and meet surging domestic agricultural and industrial demand. Accounting for about 13.7% of the expected global capacity additions by 2030, India is likely to emerge as the second-largest contributor to those additions, […]
Read more

India CT systems market to grow at 6% CAGR through 2036, forecasts GlobalData

India’s computed tomography (CT) systems market is expected to witness steady growth, driven by rising demand for advanced diagnostic imaging, increasing healthcare infrastructure, and the growing adoption of AI-enabled CT technologies. The shift toward faster, higher-resolution and lower-dose imaging is encouraging healthcare providers to upgrade existing CT systems and expand advanced diagnostic capabilities. Amid these […]
Read more

Influencers see UPI MDR introduction in India as vital step for ecosystem monetization, reveals GlobalData

The introduction of a 0.4% Merchant Discount Rate (MDR) on Person-to-Merchant (P2M) Unified Payments Interface (UPI) transactions above INR 2,000 ($20.8) has sparked substantial debate among influencers on X. Influencers see the measure as an attempt to create a durable revenue base for banks, acquirers, and payment platforms, but they also expect merchants to test […]
Read more

Physical AI to redefine the future of robotics, says GlobalData

Physical AI marks a shift from machines that follow fixed instructions to embodied systems that perceive, reason, and act autonomously. It can be deployed in robots, autonomous vehicles, drones, and industrial systems. Commercialization began in 2026 across industries ranging from discrete manufacturing and healthcare to mining, energy, and transportation. It will accelerate from 2027 as […]
Read more

Classical Hodgkin lymphoma diagnosed incident cases to reach 28,000 across 8MM in 2035, forecasts GlobalData

The burden of diagnosed incident cases of classical Hodgkin lymphoma in the 8MM* is forecast to increase at an annual growth rate (AGR) of 0.31%, from 27,000 in 2025 to 28,000 cases in 2035, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Hodgkin Lymphoma: Epidemiology Report and Forecast,” reveals that the […]
Read more

Autoliv’s Toyota onboarding for HBM suite highlights race to industrialize virtual crash testing, says GlobalData

Virtual safety engineering is moving from a research and development (R&D) adjunct to a core pillar of vehicle development as automakers face shorter product cycles, stricter consumer-safety expectations, and rising complexity from electrification and advanced driver-assistance systems (ADAS). Against this backdrop, Autoliv onboarding Toyota as the first customer to assess its Human Body Model (HBM) […]
Read more

Americas to lead global microgrids market growth through 2030, forecasts GlobalData

The global microgrids market is poised for strong growth as governments, utilities, commercial facilities, military bases, and remote communities increase investment in resilient, decentralized, and digitally managed power systems. Rising grid reliability concerns, extreme weather events, renewable energy integration, and the need for a secure and reliable power supply are accelerating microgrid deployment across critical […]
Read more

Mobileye Drive’s permit share in Germany points to more regulated, fleet-led path for Level 4 autonomy, says GlobalData

The autonomous vehicle (AV) market is increasingly bifurcated: most near-term revenues are coming from advanced driver assistance and limited “supervised” automation in consumer cars, while Level 4 progress is being concentrated in geofenced pilots for shuttles, ride-pooling, and goods movement where regulators can tightly define operating conditions. Against this backdrop, Mobileye Drive’s significant share of […]
Read more

Influencers see Apple’s latest iPhone launch as strategic pricing reset to lift premium mix, reveals GlobalData

Apple’s latest product launch during the recent “Surprise and Shine” event sparked strong reactions from influencers on X. While the iPhone Duo’s price drew immediate attention, influencers also pointed to Apple’s simultaneous price increases across older and mainstream iPhone models as evidence that the company is resetting the pricing structure of its wider portfolio. Many […]
Read more

Mabwell’s 9MW1911 data support further testing of ST2 blockade in COPD, says GlobalData

At the European Respiratory Society (ERS) Congress 2026, Mabwell and collaborating investigators presented results from the company’s Phase Ib/IIa study in patients with chronic obstructive pulmonary disease (COPD). The randomized, double-blind, placebo-controlled trial evaluated the therapeutic efficacy and safety of 9MW1911, an anti-ST2 monoclonal antibody, in moderate-to-severe COPD. Although the efficacy findings were exploratory and […]
Read more
1 2 3 … 137